Promedior

New class of pentraxin therapeutics to treat rare fibrotic diseases, including: idiopathic pulmonary fibrosis (IPF), myelofibrosis, and fibrovascular...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Promedior plus 5267 other startups.

Start Free 7 Day Trial Now

Learn More About Promedior

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Our Clients